Lee Faulkner is a Cardiology physician. OpenAlex indexes 52 publications with 1,785 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6005 Park Ave Ste 702
Memphis, TN 381195217
Telephone
901-682-7241Provider last certified this registry record 4 Mar 2020.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Saluda Medical Americas, Inc.Program year20252 payments
- PFIZER INC.Program year20251 payment
- Kestra Medical Technology Services, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
77.1%Calcium channel blocker23.6%Diltiazem 24hr Er (Cd)73%Amlodipine Besylate17%Cartia Xt7%Diltiazem 24hr Er4%Part D<11 patientsBeta blocker18.9%Metoprolol Tartrate29%Carvedilol26%Labetalol Hcl17%Metoprolol Succinate16%Atenolol7%Sotalol5%Part D<11 patients+ 13 more classes in this area
Blood & clotting
10.9%Factor Xa inhibitor7.4%Eliquis83%Xarelto17%Part D<11 patientsP2Y12 inhibitor3.5%Clopidogrel100%Part D≥15 patientsMetabolism & gastrointestinal
9.9%Potassium supplement9%Potassium Chloride100%Part D≥35 patientsSGLT2 inhibitor0.9%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Development of an Improved T-cell Assay to Assess the Intrinsic Immunogenicity of Haptenic Compounds
Toxicological Sciences
2020 - Application of in Vitro T Cell Assay Using Human Leukocyte Antigen-Typed Healthy Donors for the Assessment of Drug Immunogenicity
Chemical Research in Toxicology
2018 - HLA-A*33:03-Restricted Activation of Ticlopidine-Specific T-Cells from Human Donors
Chemical Research in Toxicology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”